Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential High-Dose VIP Plus Stem Cell Support Versus BEP in Poor Prognosis Germ Cell Cancer
NCT00003941Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Apr 1999
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of cisplatin, etoposide, ifosfamide in Germ cell cancer (GCT), sponsored by European Organisation for Research and Treatment of Cancer. Started Apr 1999; status: completed.
02
Drugs
cisplatinetoposideifosfamide
03
Conditions
Germ cell cancer (GCT)
Beyond the preview
Go deeper on NCT00003941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003941.